Oct 29, 2019 - Incyte (INCY) reports better-than-expected results for the third quarter of 2019, owing to strong Jakafi sales.
Oct 28, 2019 - Four drug/biotech stocks are scheduled to release third-quarter results on Oct 29. Let's see how these companies are placed before their earnings call.
Oct 28, 2019 - Value investing is all about being willing to buy solid companies when the market throws a sale.
Oct 24, 2019 - LLY earnings call for the period ending September 30, 2019.
Oct 23, 2019 - Eli Lilly and Company (NYSE:LLY) Q3 2019 Earnings Conference Call October 23, 2019 09:00 ET Company Participants Kevin Hern - VP IR Dave Ricks - Chairman & CEO Josh Smiley - CFO Dan Skovronsky - P
Oct 23, 2019 - The big drugmaker seemingly did what it needed to do in Q3. Except for one thing.
Oct 22, 2019 - Four drug/biotech stocks are scheduled to release third-quarter results on Oct 23. Let's see how these companies are placed before their earnings call.
Oct 17, 2019 - Lilly's (LLY) immunotherapy candidate, pegilodecakin, falls short of meeting the primary endpoint of OS benefit in a phase III study investigating its usage in metastatic pancreatic cancer.
Oct 17, 2019 - Eli Lilly and Company's (LLY) new drugs like Trulicity, Taltz and Jardiance are likely to have performed well. Let's see if these along with its older products lead to an earnings beat for the company in Q3.
Oct 16, 2019 - Lilly (LLY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.